Cardio-respiratory changes and mortality in the conscious rat induced by (+)- and (±)- anatoxin-a by Adeyemo, M. & Sirén, Anna-Leena
Toxlcott, Vol. JO. No. 8, pp. 199-90~. 1992. 
Priatcd ia Great Britain. 
0041-0101/92 s~.oo + .oo 
C 1992 Papmoa Pn:u Ltd 
CARDIO-RESPIRATORY CHANGESAND MORTALITY IN THE 
CONSCIOUS RAT INDUCED BY ( + )- AND ( + )-ANATOXIN-a 
OLUWADARE M. ADEYEMO and ANNA-LBENA SIREN 
Department of Neurology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, 
Bethesda, MD 20889-4799, U .S.A. 
(Received 18 November 1991; accepled 13 February 1992) 
0. M. ADEYEMO and A.-L. SIREN. Cardio-respiratory changes and mortality in 
the conscious rat induced by ( + )- and ( ± )-anatoxin-a. Toxicon 30, 899-905, 
1992.-Anatoxin-a (AnTx-a) isapotent nicotinic cholinergic receptor agonist. 
The relative potencies of the ( + )-AnTx-a and the racemic mixture ( ± )-AnTx-
a were investigated in the conscious rat by comparing their effects on mean 
arterial blood pressure (BP), heart rate (HR), blood oxygen and carbon 
dioxide pressures (p02 and pC02, respective1y), acid-base balance (pH) and 
mortality. The present experiments show that while both forms of AnTx-a 
produce dose-dependent increases in BP and decreases in HR, ( + )-AnTx-a is 
about IO-fo1d morepotent than the optically inactive isomer. ( + )-AnTx-a was 
also 6-fo1d more potent than ( ± )-AnTx-a in produclog severe hypoxemia, and 
more than 4-fold as potent as the (±}-AnTx-a in producing significant 
hypercapnia accompanied with severe acidosis. The approximate median Iethai 
dose (Ln so) of ( + )-AnTx-a was about 5-fold less than that of ( ± )-AnTx-a. We 
conclude that ( + )-AnTx-a is more potent than the ( ± )-AnTx-a racemic 
mixture in causing detrimental cardio-respiratory changes and therefore 
increased mortality in the rat. 
INTRODUCilON 
ANATOXIN-a (AnTx-a) is a naturally occurring semirigid alkaloid neuroto:xin with a 
bicyclic secondary amine structure, isolated from the blue-green algae Anabaena jlos-
aquae (CARMICHAEL et al., 1975; KOSKINEN and RAPOPORT, 1985). This neurotoxinwas 
shown to be a potent stereospecific agonist at nicotinic synapses in torpedo electric organs 
and frog musc1e (CAR.MICHAEL et a/., 1979; ARONSTAM and WITKOP, 1981; ALBUQUERQUE 
and SPIVAK, 1984; SWANSON et a/., 1986; ARACAVA et a/., 1988; ALBUQUERQUE et a/., 1989). 
In vitro studies have shown that ( + )-AnTx-a was more than twice as potent as the 
racemic mixture ( ± )-AnTx-a on nicotinic receptor mediated contractile response of rectus 
abdominis muscle of the frog Rana-pipiens (SPIV AK et al., 1980, 1983). The ( + )-AnTx-a 
was also more than 50-fold more potent than ( ± )-AnTx-a in inhibiting the specific 
binding of [1 251]-~X-bungarotoxin to the nicotinic receptors in torpedo e1ectric organ 
(SWANSON et al., 1986). In the rat brain, ( + )-AnTx-a binds to nicotinic receptors with a 
20-fold higher potency than (±)-AnTx-a and was more than 160-fold as potent as (- )-
AnTx-a in inhibiting [3H]-acetylcholine binding to the rat's cortex, suggesting that the 
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enantiomer (- )-AnTx-a in the racenuc mixture is a weak agonist (SWANSON et al., 1986; 
ZHANG et al., 1987; KoFUJI et al., 1990). 
The existence of different subtypes of nicotinic receptors in the rodent brain has been 
described by LARSSON and NoRDBERG (1985). In recent studies, the affinities of ( + )- and ( ± )-AnTx-a for the nicotinic receptors were ~hown to be significantly different. ( + )-
AnTx-a binds to high affinity sites (Kd = 6 nM) while ( ± )-AnTx-a binds to low affinity 
sites (Kd = 125 nM) of nicotinic receptor in the rat's cortex (ZHANG et al., 1987; 
NoRDBERG et al., 1988; KoFUJI et al., 1990). The present studies were undertaken to 
investigate in vivo the role of enantiomorphism of the AnTx-a molecule. Thus, mean 
arterial pressure, heart rate, respiratory gases, and mortality were monitored after 
systemic administration of ( + )- or ( ± )-AnTx-a in the conscious rat. 
MATERIALSAND METHODS 
Male Sprague-Dawley rats (Taconic Farms, Gennantown, NY, U.S.A.) weighing 310 ± 5 g (n = 60) were 
housed in a temperature-<:ontrolled room with a 12/12 hr Iight/dark cycle and access to food and water ad 
lihitum. 
Metl3Urement of blood pressure, heart rate, blood gases, pH, and mortality 
Each rat was anesthetized with halothane (2% in oxygen) and PE-SO catheters were inserted into the right 
femoral artery and vein. The catheters were tunneled under the skin and exited at the back of the neck. All rats 
were allowed 3-5 hr to fully recover and stabilize from surgery. The arterialline was connected to a pressure 
transducer (Narco Bio-Systems model RP I 500) attached to a strain gauge coupler (Narco Bio-Systems Type 
7179). Blood pressure and hcart rate were recorded on a Narcotrace 80 computerizcd physiograph and sampled 
manually u required via a Northstar Hazeltine computer. 
All drugs and saline were administered through the i.v. line in a total volume of0.2 ml which was immediately 
followed with a 0.3 ml saline wash. The response to drug administration was obvious immediately after injection 
with peak efl'cct within l-2 min, which completely subsided in about 15 min. Sampies for all parameters except 
mortality data were taken within this peak effect period. 
For the blood gas mcasurements, a sample (0.4 ml) of heparinized arterial blood was taken via the arterial 
catheter immediately before anatoxin-a or saline treatments and at the peak of the cardiovascular response. 
Equal volumes of saline were used for the replacement of blood withdrawn. These samples were immediately 
analyzed for p021 pC02, and pH values, using a ST AT Profile 3 blood gas analyzer (Nova Biomedical, Waltham, 
MA, U.S.A.). Mortality data were monitored at all AnTx-a dose Ievels within an Observation period of 30 min 
because if the dose was not fatal, total recovery from AnTx-a effects usually occurred about 15 min after the 
administration of AnTx-a. All surviving rats were monitored for 2 hr and finally sacrificed with T-61 euthanasia 
solution containing embutramide, mebezonium iodide, and tcctracaine hydrochloride. 
Drugs used ( + )-AnTx-a was purchased froiil Bio-Metrie Systems, lnc. (Eden Prairie, MN, U.S.A.). (±)-AnTx-a was 
synthesizcd by Dr RlcK L. DANHEISER (MIT) (DANHEISER et al., 1985). ( + )- and (±}AnTx-a were dissolved in 
ethanol separately and the stock solutions were stored at - 20°C under argen until used. At the time of use, the 
drugs were reconstituted in physiological saline (0.9%) and injccted. T-61 euthanasia solution was purchased 
from Hoechst (Somerville, NJ, U.S.A.). 
Statiftical analysu of the data 
Data in figurcs are mean ± S.E. for indicated number of rats. Analysis of variance (ANOV A) followed by 
Dunnett's testwas used to analyze data. The approximate median Jethaidose (LD~ of( +} and (±)-AnTx-a in 
rat was calculated according to the Spearman-Kärber method (FINNEY, 1978). A signifi.cant changewas accepted 
at P < 0.05. 
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FIG. 1. EFFECT OF i. V. ADMINISTERED ( + r AND ( ± }AnTx-a ON MEAN ARTEIUAL BLOOD PltaiSURE (A, 
UPPBR PANEL) AND HEART RATE (8, LOWER PANEL) IN THE CONSCIOUS KAT. 
The values (mean ± S.E.) indicate maximum changes from baseline. Onset ofresponse was within 
S-10 sec, with duration of action of about 15 min and peak effect within 2 min following drug 
treatment. Closed circles denote the effect of saline (S), open circles denote the effects of ( + r 
AnTx-a, and open triangles denote the effect of ( ± }AnTx-a. Asterlab indicate significant 
difference from saline control (Dunnett's test). Number of animals is 4-6 rats per dose. 
RESULTS 
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Different doses of ( + )- and ( ± )-AnTx-a ranging from 1 to 500 Jl8/kg were injected i. v. 
into the rat (n = 4-6 per dose Ievel) and changes in BP, HR, p02, pC02, and pH were 
monitored. Each animal received a single dose of the drug to prevent any cumulative bias. 
8oth the ( + )-AnTx-a and ( ± )-AnTx-a produced simultaneaus dose-dependent increases 
in BP and decreases of more than 100 beats per min in HR. ( + )-AnTx-a produced 
significant changes in BP and HR at lower doses of 10 to 50 J.lgfkg as compared to the 
(±)-racemic mixture at relatively higher i.v. doses of 100 to 300 Jlg/kg (Fig. 1). Potency 
comparisons between the two forms of AnTx-a showed that the (+)-form was about 10-
fold morepotent than the ±-isomer. 
( + )-AnTx-a induced significant hypoxemia in the rat at a dose of 50 1'8/kg, i. v ., while a 
significant decrease in the arterial p02 was not observed with ( ± )-AnTx-a until the 
relatively high dose of 300 llgfkg, i.v. (Fig. 2A). Similar responses were observed with 
changes in pC02 values. Significant hypercapnia was evident with ( + )-AnTx-a treatment 
at 70 J.lg/kg, i.v., as compared to 300 pgfkg, i.v. for (±)-AnTx-a (Fig. 2B). ( + )-AnTx-a 
treatment caused hypercapnia accompanied by severe acidosis (P < 0.05), while ( ± )-
AnTx-a even at higher doses failed to produce any significant change in arteria1 blood 
acid-base balance (Fig. 2C). 
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FIG. 2. EJiFEcT OF i.v. ADMINOO'EIUID ( + )· AND (±)-AnTx-a ON BLOOD GASBS: p02 (A, UPPER·PANEL), 
pC02 (8, MIDDLE PANEL), AND ACID-BASE BALANCE (pH) (C, LOWER PANEL) IN THE CONSCIOUS RAT. 
The values are mean ± S.E. Closed triangles denote tbe baseline (8), open circles denote the effcct 
of ( + )-AnTx-a, and closed circles denote the effcct of ( ± )-AnTx-a. Signific:ant differences from 
baselineare indicatcd by asterisks (Dunnett's). Number of animals is ~ rats per dose. 
The time-courses of the autonomic effects of both the (+)-isomer and the (±)-isomer 
were identical. The changes in cardiovascular and respiratory gases became apparent 
5-10 sec after AnTx-a administration and subsided within 5--15 min. The peak effect was 
reached at about 2 min after i.v. injections. Usually, all rats surviving for more than 
30 min after AnTx-a treatments survived indefinitely. Therefore, the duration for the 
approximate LDso calculations was 30 min. The i.v. LDso dosein rats for ( + )-AnTx-a was 
~ 85 JJ8fkg, and for ( ± )-AnTx-a was ~ 400 Jlg/kg (Fig. 3). 
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F'lo. 3. THE I.JmiAL EPfECl' OP i.v. ADMINISTERED ( + )- AND (±)-AnTx-a IN TIIE CONSCIOUS RAT. 
The approximate median Iethai dose (LD,J witbin a 30-min period of observation is calculated 
using the Speannan-Kiber method. Tbc i.v. LD"' for ( + )-AnTx-a is ~ 8S !Jg/kg, and for ( ± )-AnTx-a is ~ 400 Jlg/kg. Open circles denote the Iethai effect of ( + )-AnTx-a and closed circles 
represent the Iethai etfcct of (±)-AnTx-a in rat. Number of animals is 4-6 rats per dose. 
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DISCUSSION 
In the present study, ( + )-AnTx-a was more potent than ( ± )-AnTx-a in producing 
severe disturbances in cardiovascular parameters and respiratory gases. ( + )-AnTx-a 
produced significant changes in BP, HR, p02, pC02, and pH at lower i.v. doses than the ( ± )-racemate. Furthermore, the approximate LD~ dose (or the ( + )-AnTx-a was about 
5-fold less than that of ( ± )-AnTx-a. The data and visual Observations from the present 
experiment suggest that drug-induced mortality is associated with severe changes in blood 
gases (primarily hypoxia) brought about by a combination of direct cardiovascular effects, 
and respiratory paralysis caused by AnTx-a. 
The difference in potencies between ( + )- and (±)-AnTx-a, as shown by changes in BP 
and HR, is most likely associated with their binding affinities for and stimulation of the 
nicotinic cholinergic receptors. Previous in vitro studies have shown that the ( + ), (- ), and 
( ±) isomers of AnTx-a bind to the nicotinic receptors with varying affinities (SWANSON et 
al., 1986; ZHANG et al., 1987). When the relative potencies (Icso) of AnTx-a isomers and 
nicotine were compared, ( + )-AnTx-a was more than 20-fold more potent than ( ± )-
AnTx-a and twice as potent than nicotine in inhibiting [3H]-acetylcholine specific binding 
at the receptor site in the rat brain (ZHANG et al., 1987). Also in recent studies from our 
Iabaratory, ( ± )-AnTx-a was more than 1 0-fold less potent than nicotine (SIREN and 
FEUERSTEIN, 1990). Thus the reduced potency of the ( ± )-AnTx-a may be due to its 
binding to the low affinity site which is not known to mediate any physiologic responses. 
In explaining a probable mechanism for AnTx-a toxicosis, based upon the present data, 
a similar nicotine-associated hemodynamic disturbance could be considered. Nicotine is 
known to exert its effects at both peripheral and central sites in the nervous system. It has 
also been shown to produce increased blood pressure associated with stimulation of the 
sympathetic ganglia, adrenal medulla, carotid and aortic chemoreceptor, and direct 
vasomotor stimulation (CoMROE, 1960; ARMITAGE, 1965). Similarly to nicotine, 
AnTx-a-induced hemodynamic changes were believed to be associated with its effects on 
multiple sites in the nervous system. For example, SIR.EN and FEUERSTEIN (1990) reported 
that the increased blood pressure observed in the rat following AnTx-a administration was 
caused by increases in cardiac output and vasoconstriction in the renal and mesenteric 
circulation. Furthermore, the accompanying bradycardia was associated with reftex vagal 
activation since the vasoconstrictive response came first. These effects were believed tobe 
mediated by nicotinic receptors, as evidenced by the complete blockade of these AnTx-a 
effects by chlorisondamine. 
Blood gases are among the most fundamental of all tests of pulmonary performance. 
The occurrence of hypoxia in concert with hypercapnia suggest severe hypoventilation 
and circulatory insufficiency. The severe hypoxia observed in the present experiment may 
be brought about by the direct effect of AnTx-a on the respiratory muscles and the 
diaphragm, resulting in paralysis. This conclusion is supported by studies of CARMICHAEL 
et al. (1975) and VALENTINE et al. (1991). Generally, hypoxia is associated with inter-
actions between reflex, nerve-mediated responses, and local inftuence of blood gas tension 
changes, e.g. reftex effects of peripheral chemoreceptors stimulation by hypoxia or direct 
effects of pC02 and p02 (DAL v, 1986). The occurrence of bradycardia in the presence of 
vasoconstriction in most vascular beds, a phenomenon attributable to sustained Stimula-
tion of peripheral carotid bodies with hypoxic blood, has been reported in other sturlies 
(DALY, 1983., 1986). 
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Since adequate delivery of oxygen to the brain is of prime importance for proper CNS 
function, the Observation that AnTx-a-induced hypoxia was accompanied by severe and 
sometimes fatal acidosis suggests that brain hypoxia at the cellular Ievel may result in the 
accumulation of Iactate via anaerobic glycolysis produclog acid-base stress, probable loss 
of reducing equivalents, and rapid depletion of high-energy phosphate compounds 
produced through oxidative phosphorylation. HITZIG (1989) reported that brain cells are 
resistant to moderate hypoxia and can compensate for acid-base imbalance associated 
with hypoxia; but under severe hypoxia, brain cells lose their compensatory ability. This 
may explain why not all the animals treated with median doses of the more potent ( + )-
AnTx-a survived and relatively large doses of the less potent ( ± )-AnTx-a were not fatal in 
some animals. We therefore conclude from our data that the depression of the brain 
respiratory center brought about by pronounced hypoxia, followed by respiratory acido-
sis, and compounded by respiratory muscle paralysis are contributing factors to the 
expression of toxicity to AnTx-a. This study provides direct evidence for additional 
mechanisms of toxicity by AnTx-a . 
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